Drug class in one race
Cereblon E3 ubiquitin-ligase drugs for Multiple Myeloma
8 tracked Cereblon E3 ubiquitin-ligase drugs in the Multiple Myeloma race. The class explanation lives on the Cereblon E3 ubiquitin-ligase page; the full indication pipeline across every mechanism is on the Multiple Myeloma page.
3 approved / phase 42 Phase 31 Phase 21 Phase 1/21 preclinical / unstaged
Head-to-head evidence: Cemsidomide vs ICP-490 · Cemsidomide vs Lenalidomide · Cemsidomide vs Pomalidomide · Cemsidomide vs Thalidomide · Iberdomide vs ICP-490 · ICP-490 vs Lenalidomide